Crossmark

Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics

Crossref DOI link: https://doi.org/10.1186/s12014-020-09309-3

Published Online: 2021-01-07

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boylan, Kristin L. M.

Afiuni-Zadeh, Somaieh

Geller, Melissa A.

Argenta, Peter A.

Griffin, Timothy J.

Skubitz, Amy P. N. https://orcid.org/0000-0003-4672-3450
Funding

Funding for this research was provided by:

Minnesota Ovarian Cancer Alliance

Charlene’s Light…A Foundation for Ovarian Cancer

U.S. Department of Defense (W81XWH-16-1-0070)
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 19 August 2020

Accepted: 14 December 2020

First Online: 7 January 2021

Ethics approval and consent to participate

: This study was approved by the University of Minnesota Institutional Review Board, protocol 1112M07362.

: Not applicable.

: The authors declare that there are no conflicts of interest.

Document is current

Any future updates will be listed below